| 000 | 01894 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514232836.0 | ||
| 264 | 0 | _c20050920 | |
| 008 | 200509s 0 0 eng d | ||
| 022 | _a0009-9104 | ||
| 024 | 7 |
_a10.1111/j.1365-2249.2005.02859.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVigna-Pérez, M | |
| 245 | 0 | 0 |
_aImmune effects of therapy with Adalimumab in patients with rheumatoid arthritis. _h[electronic resource] |
| 260 |
_bClinical and experimental immunology _cAug 2005 |
||
| 300 |
_a372-80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdalimumab |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntigens, Bacterial _ximmunology |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmune Tolerance _xdrug effects |
| 650 | 0 | 4 | _aLymphocyte Count |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _ximmunology |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 |
_aT-Lymphocyte Subsets _xdrug effects |
| 650 | 0 | 4 | _aTuberculin Test |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aAbud-Mendoza, C | |
| 700 | 1 | _aPortillo-Salazar, H | |
| 700 | 1 | _aAlvarado-Sánchez, B | |
| 700 | 1 | _aCuevas-Orta, E | |
| 700 | 1 | _aMoreno-Valdés, R | |
| 700 | 1 | _aBaranda, L | |
| 700 | 1 | _aParedes-Saharopulos, O | |
| 700 | 1 | _aGonzález-Amaro, R | |
| 773 | 0 |
_tClinical and experimental immunology _gvol. 141 _gno. 2 _gp. 372-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2249.2005.02859.x _zAvailable from publisher's website |
| 999 |
_c15652919 _d15652919 |
||